A new approach to tissue rejuvenation
Fount Bio is a clinical-stage life sciences company developing innovative, glycopolymer-based products to revitalize tissues. Based on the Nobel Prize-winning field of bioorthogonal chemistry, our proprietary, click-chemistry-based technology platform overcomes longstanding challenges associated with glycopolymer delivery into, and retention within, target tissues. Current products under development are directed to both the medical aesthetics and consumer beauty markets.
Fount Bio Awarded Prestigious Innovation of the Year at 2024 IMCAS
Fount Bio wins first prize at the Innovation Tank competition for its development of the world’s first platform of products that build crosslinked hyaluronic acid within living tissues
Catch a new wave of innovation
At Fount Bio, we have a bold ambition: to define new categories of high-impact products that generate tremendous value for patients and providers—and tremendous opportunities for our employees. Sound like your kind of challenge?